rheumatism rheumatoid arthritis
Conditions
Interventions
None listed
Sponsors
Academisch Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Male and female patients of more than 18 years old diagnosed with arthralgia and anti-citrullinated peptide antibodies and/ or rheumatoid factor. - Having given written informed consent prior to undertaking any study-related procedures. - Covered by a health insurance system where applicable, and/or in compliance with the recommendations of the national laws in force relating to biomedical research.
Exclusion criteria
Exclusion criteria: - Under any administrative or legal supervision. - Conditions/situations such as: • Patients with conditions/concomitant diseases making them non evaluable for the primary endpoint • Impossibility to meet specific protocol requirements (e.g. blood sampling) • Patient is the Investigator or any sub-investigator, research assistant, pharmacist, study coordinator, other staff or relative thereof directly involved in the conduct of the protocol • Uncooperative or any condition that could make the patient potentially non-compliant to the study procedures
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The inclusion of approximately 75 individuals who have RA associated autoantibodies and arthralgia, in whom we successfully collect blood (and tissue) samples to study dominant clones. Completion of the study period or development of RA will mean the end of the study. | — |
Secondary
| Measure | Time frame |
|---|---|
| - | — |
Countries
Netherlands
Outcome results
None listed